UPL working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
162.07×162.07×173.98×199.39×181.04×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
117.51×117.51×124.67×146.42×114.29×
161.31×161.31×200.04×248.10×235.66×
118.27×118.27×98.61×97.71×59.67×
7.12×6.99×4.22×3.47×4.14×
0.57×0.57×0.53×0.49×0.63×
3.54×3.54×12.38×−0.97×1.76×
0.85×0.85×1.34×0.40×0.76×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

UPL₹541.95

UPL Ltd.

· Chemicals
₹ CrorePeersPIINDSUMICHEMRALLISCOROMANDELSRFSOLARINDSPIDILITINDBASFMcap ₹45,795 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)181.04199.39173.98162.07162.07
Receivable Days (DSO)114.29146.42124.67117.51117.51
Payable Days (DPO)235.66248.10200.04161.31161.31
Cash Conversion Cycle (days)59.6797.7198.61118.27118.27
Working Capital Turnover4.143.474.226.997.12
Asset Turnover0.630.490.530.570.57
Cash Conversion (CFO/Net Income)1.76-0.9712.383.543.54
CFO/EBITDA0.760.401.340.850.85
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.